Legal & General Group Plc lowered its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 3.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 282,908 shares of the company's stock after selling 9,505 shares during the quarter. Legal & General Group Plc owned about 0.17% of Option Care Health worth $6,563,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in Option Care Health by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company's stock valued at $448,118,000 after buying an additional 75,313 shares in the last quarter. Wellington Management Group LLP grew its position in shares of Option Care Health by 84.6% during the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after buying an additional 8,400,208 shares in the last quarter. Norges Bank purchased a new position in shares of Option Care Health during the fourth quarter valued at $60,219,000. Charles Schwab Investment Management Inc. lifted its stake in Option Care Health by 6.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock worth $58,235,000 after acquiring an additional 147,054 shares during the period. Finally, Magnetar Financial LLC grew its holdings in Option Care Health by 23.1% during the 4th quarter. Magnetar Financial LLC now owns 2,350,598 shares of the company's stock worth $54,534,000 after acquiring an additional 441,265 shares in the last quarter. Institutional investors own 98.05% of the company's stock.
Insider Activity at Option Care Health
In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.64% of the stock is owned by insiders.
Option Care Health Stock Performance
OPCH traded up $0.24 on Thursday, reaching $32.35. 721,758 shares of the stock were exchanged, compared to its average volume of 1,920,752. The company's 50-day moving average price is $33.33 and its 200 day moving average price is $28.70. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The firm has a market capitalization of $5.31 billion, a PE ratio of 27.19, a PEG ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on OPCH shares. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Barrington Research reaffirmed an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research report on Monday. JPMorgan Chase & Co. raised their price objective on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. JMP Securities reiterated a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a report on Tuesday. Finally, Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and raised their price target for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $33.75.
Read Our Latest Report on Option Care Health
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Stories
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
